Good News About Multiple Myeloma

By sulthan on Friday, August 18, 2017

Multiple myeloma news 2017 - Combining the proteasome inhibitor Kyprolis (carfilzomib) with dexamethasone is beneficial for person patients with multiple myeloma who have obtained at the least one prior therapy, the Scottish drug treatments Consortium (SMC) determined.




The SMC advises the Scottish countrywide health carrier (NHS) boards and their Area Drug and Therapeutics Committees (ADTCs)